NASDAQ:ORKA

Oruka Therapeutics Stock Insider Trading

*Your capital is at risk

$57.20

+1.97 (+3.57%)

At Close: Jun 03, 2026

Oruka Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -30.36. In total, the insiders bought 2.32M and sold 184.39K ORKA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-30.36
● Buy	2.32M shares
● Sell	184.39K shares
60% Buy Activity Strong Negative Correlation
Sell Signal Medium Confidence May 21, 2026 Analysis Breakdown: Supported by a negative Insider Power Score of -30.36. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
May 01, 2026 Sell	Common Stock S-Sale	Sandler Laura Lee Chief Operating Officer	C-Suite Officer	2 200 Value: $137.7K
May 01, 2026 Sell	Common Stock S-Sale	Sandler Laura Lee Chief Operating Officer	C-Suite Officer	1 800 Value: $115.5K
May 01, 2026 Sell	Common Stock S-Sale	Sandler Laura Lee Chief Operating Officer	C-Suite Officer	300 Value: $19.5K
May 01, 2026 Sell	Common Stock S-Sale	Sandler Laura Lee Chief Operating Officer	C-Suite Officer	400 Value: $26.4K
May 01, 2026 Sell	Common Stock S-Sale	Sandler Laura Lee Chief Operating Officer	C-Suite Officer	200 Value: $13.4K
May 01, 2026 Sell	Common Stock S-Sale	Sandler Laura Lee Chief Operating Officer	C-Suite Officer	100 Value: $7K
May 01, 2026 Buy	Employee Warrant (right to buy) M-Exempt	Sandler Laura Lee Chief Operating Officer	C-Suite Officer	5 000 Value: $39.0K
Apr 15, 2026 Buy	Employee Stock Option (right to buy) M-Exempt	Goncalves Joana Chief Medical Officer	Officer	3 500 Value: $23.9K
Apr 15, 2026 Buy	Employee Warrant (right to buy) M-Exempt	Goncalves Joana Chief Medical Officer	Officer	3 500 Value: $27.3K
Apr 15, 2026 Buy	Common Stock M-Exempt	Goncalves Joana Chief Medical Officer	Officer	3 500 Value: $27.3K
Apr 15, 2026 Buy	Common Stock M-Exempt	Goncalves Joana Chief Medical Officer	Officer	3 500 Value: $23.9K
Apr 15, 2026 Sell	Common Stock S-Sale	Goncalves Joana Chief Medical Officer	Officer	4 227 Value: $277.8K
Apr 15, 2026 Sell	Common Stock S-Sale	Goncalves Joana Chief Medical Officer	Officer	2 273 Value: $151.3K
Apr 15, 2026 Sell	Common Stock S-Sale	Goncalves Joana Chief Medical Officer	Officer	500 Value: $33.7K
Mar 16, 2026 Sell	Common Stock S-Sale	Klein Lawrence Otto Chief Executive Officer	CEO / President	1 729 Value: $71.4K
Mar 16, 2026 Sell	Common Stock S-Sale	Agarwal Arjun Senior Vice President, Finance	CEO / President	395 Value: $16.3K
Mar 16, 2026 Sell	Common Stock S-Sale	Sandler Laura Lee Chief Operating Officer	C-Suite Officer	600 Value: $24.8K
Mar 16, 2026 Buy	Employee Stock Option (right to buy) M-Exempt	Goncalves Joana Chief Medical Officer	Officer	3 500 Value: $23.9K
Mar 16, 2026 Buy	Employee Warrant (right to buy) M-Exempt	Goncalves Joana Chief Medical Officer	Officer	3 500 Value: $27.3K
Mar 16, 2026 Buy	Common Stock M-Exempt	Goncalves Joana Chief Medical Officer	Officer	3 500 Value: $27.3K
Mar 16, 2026 Sell	Common Stock S-Sale	Goncalves Joana Chief Medical Officer	Officer	2 921 Value: $117.2K
Mar 16, 2026 Buy	Common Stock M-Exempt	Goncalves Joana Chief Medical Officer	Officer	3 500 Value: $23.9K
Mar 16, 2026 Sell	Common Stock S-Sale	Goncalves Joana Chief Medical Officer	Officer	2 902 Value: $119.6K
Mar 16, 2026 Sell	Common Stock S-Sale	Goncalves Joana Chief Medical Officer	Officer	1 177 Value: $49.4K
Mar 16, 2026 Sell	Common Stock S-Sale	Goncalves Joana Chief Medical Officer	Officer	641 Value: $26.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks